Invesco
PROK icon

Invesco’s ProKidney PROK Stock Holding History

Invesco’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32,258
Closed -$28.3K – 3843
2025
Q1 		$28.3K Buy
32,258
+135
+0.4% +$187 ﹤0.01% 3732
2024
Q4 		$54.3K Buy
32,123
+1,643
+5% +$2.96K ﹤0.01% 3685
2024
Q3 		$58.5K Buy
30,480
+2,617
+9% +$5.94K ﹤0.01% 3670
2024
Q2 		$68.5K Sell
27,863
-240
-0.9% -$644 ﹤0.01% 3792
2024
Q1 		$46.1K Sell
28,103
-833
-3% -$1.22K ﹤0.01% 3810
2023
Q4 		$51.5K Sell
28,936
-11,710
-29% -$25.1K ﹤0.01% 3748
2023
Q3 		$186K Buy
40,646
+14,578
+56% +$140K ﹤0.01% 3613
2023
Q2 		$292K Buy
+26,068
New +$277K ﹤0.01% 3506

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco's PROK Position: Q2 2025 in Review

Invesco sold out of ProKidney (PROK) in Q2 2025, closing a stake of 32,258 shares — an estimated $28.3K sold.

Invesco first reported a position in PROK in Q2 2023 and held it in 8 quarters. The position peaked at $292K in Q2 2023. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • Invesco reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 32,258 ProKidney shares in Q2 2025, an estimated $28.3K.
  • Invesco first reported a position in ProKidney in Q2 2023 and held it in 8 quarters.
  • Invesco's ProKidney position peaked at $292K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.